Intrexon | XON - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Agenus USD -271.11M 3.03M 2025-12
Alaunos Therapeutics USD 2.15M 650K 2025-12
Amgen USD 8.66B 961M 2025-12
Anika Therapeutics USD 133.9M 9.56M 2026-03
Arrowhead Research USD 568.42M 102.37M 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Heron Therapeutics USD 13.28M 1.6M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Intrexon USD 43.17M 75.33M 2024-06
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
MannKind USD -51.02M 6.47M 2025-12
Merck USD 52.61B 756M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Veracyte USD 1.26B 36.61M 2025-09
Xencor USD 635.59M 10.27M 2025-12